Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BIOSYNEX

Biosynex designs, manufactures and distributes Rapid Diagnostic Tests (RDTs) which, in their professional version, al... read more Featured Products: More products

Download Mobile App




Pocket Laboratory Offers Fast and Reliable Diagnosis at Point of Care

By LabMedica International staff writers
Posted on 10 Apr 2023

A multi-technology, multi-parameters Point of Care (PoC) device combines two technologies in a single device for a unique evolutive panel of tests. More...

The pocket-sized lab can perform multiple biological analyses from just a finger prick of blood and send the results via Bluetooth to a smartphone or tablet.

LabPad Evolution from Biosynex SA (Illkirch-Graffenstaden, France) is a handheld PoC device that healthcare professionals can use to perform multiple lab-quality measurements directly with patients. With its miniature automated microscope built from two CMOS sensors, the LabPad Evolution can carry out blood tests from a single finger prick. The device uses compatible single-use SmartChip tests that are available in two formats: Tsmart and Ksmart, each for different types of testing. Tsmart is intended for coagulation testing as INR, consisting of a microfluidic microcuvette embedding a dried or freeze-dried reagent (dry chemistry) while Ksmart is meant for lateral flow testing based on visual or fluorescent optical measurements. The LabPad Evolution automatically conducts internal quality controls before, during, and after each measurement, and displays an error message if any interference is detected.

LabPad Evolution can operate as a standalone tool, storing up to 1,000 results in its memory, which can be viewed on its screen. Additionally, the LabPad Evolution is fully connected and can transmit results automatically via USB or Bluetooth. It can integrate with information systems for centralized processes such as operator authorization/identification, patient identification, quality controls, and results validation/management. The current available SmartChip tests are for SARS-COV-2 Antigen, SARS-COV-2 Antibody, and TP/INR rapid tests. Future tests will focus on nutrition and cardiac markers.

Related Links:
Biosynex SA


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.